F. M. Moghaddam et al. / Tetrahedron Letters 54 (2013) 2685–2689
2689
6. (a) Sakai, S.; Aimi, N.; Yamaguchi, K.; Hitotsuyonagi, Y.; Watanabe, C.; Yokose,
K.; Koyama, Y.; Shudo, K.; Itai, A. Chem. Pharm. Bull. 1984, 32, 354; (b) Endo, Y.;
Shudo, K.; Faruhata, K.; Ogura, H.; Sakai, S.; Aimi, N.; Hitotsuyonagi, Y.;
Koyama, Y. Chem. Pharm. Bull. 1984, 32, 358.
Thus cis-trans annulated derivatives 3a–l are the predominant
products.
In conclusion, we have developed
a novel and efficient
7. (a) Takada, S.; Makisumi, Y. Chem. Pharm. Bull. 1984, 32, 872; (b) Takada, S.;
Ishizuka, N.; Sasatani, T.; Makisumi, Y.; Jyoyama, H.; Hatakeyama, H.; Asanuma,
F.; Hirose, K. Chem. Pharm. Bull. 1984, 32, 877.
8. (a) Yamanaka, E.; One, M.; Kasamatsu, S.; Aimi, N.; Sakai, S. Chem. Pharm. Bull.
1984, 32, 818.
9. (a) Mustafa, A. Chem. Rev. 1954, 57, 195; (b) Fischer, R. F. Ind. Eng. Chem. 1964,
56, 41; (c) Buglass, A.; Tillet, J. G. In The Chemistry of Sulfonic Acids Esters and
Their Derivatives; Patai, S., Rappoport, Z., Eds.; John Wiley & Sons: New York,
1991; p 789. Chapter 19; (d) Metz, P. J. Prakt. Chem. 1998, 340, 1.
10. (a) Wolckenhauer, S. A.; Devlin, A. S.; Bois, J. D. Org. Lett. 2007, 9, 4363; (b) John,
J. P.; Novikov, A. V. Org. Lett. 2007, 9, 61.
11. (a) Bovenschulte, V. E.; Metz, P.; Henkel, G. Angew. Chem., Int. Ed. Engl. 1989, 28,
202; (b) Metz, P.; Fleischer, M.; Froulich, R. Synlett 1992, 985; (c) Metz, P.;
Fleischer, M. Synlett 1993, 399.
procedure for the synthesis of pentacyclic thiopyrano indole-annu-
lated benzo-d-sultone derivatives via intramolecular domino
Knoevenagel hetero-Diels–Alder reactions of indoline-2-thiones
and 2-formylphenyl (E)-phenylethenyl sulfonate derivatives. The
reaction was performed in aqueous medium which is environmen-
tally friendly, and has other advantages such as high yields of prod-
ucts, ease of work-up, and proceeds via a catalyst-free procedure,
which should make it a useful and attractive procedure for the
synthesis of these types of compound.
Acknowledgment
12. (a) Enders, D.; Harnying, W.; Vignola, N. Synlett 2002, 1727; (b) Enders, D.;
Harnying, W.; Vignola, N. Eur. J. Org. Chem. 2003, 20, 3939.
We would like to acknowledge the help rendered by the Islamic
Development Bank (IDB) for granting a loan in 1993 for purchasing
a 500 MHz Bruker NMR spectrometer.
13. (a) Karsch, S.; Schwab, P.; Metz, P. Synlett 2002, 2019; (b) Karsch, S.; Freitag, D.;
Schwab, P.; Metz, P. Synthesis 2004, 1696.
14. (a) Majumdar, K. C.; Mondal, S.; Ghosh, D. Tetrahedron Lett. 2009, 50, 4781; (b)
Majumdar, K. C.; Chattopadhyay, B.; Sinha, B. Synthesis 2008, 3857.
15. (a) Meschkat, E.; Barratt, M. D.; Lepoittevin, M. D. Chem. Res. Toxicol. 2001, 14,
110; (b) Roberts, D. W.; Williams, D. L.; Bethell, D. Chem. Res. Toxicol. 2007, 20,
61.
Supplementary data
16. Perez-Perez, M. J.; Balzarini, J.; Hosoya, M.; Clercq, E. D.; Camarasa, M. J. Bioorg.
Med. Chem. Lett. 1992, 2, 647.
17. (a) Moghaddam, F. M.; Kiamehr, M.; Khodabakhshi, M. R.; Mirjafary, Z.; Fathi,
S.; Saeidian, H. Tetrahedron 2010, 66, 8615; (b) Moghaddam, F. M.; Kiamehr,
M.; Taheri, S.; Mirjafary, Z. Helv. Chim. Acta 2010, 93, 964; (c) Kiamehr, M.;
Moghaddam, F. M. Tetrahedron Lett. 2009, 50, 6723.
Supplementary data associated with this article can be found, in
References and notes
18. (a) Moghaddam, F. M.; Foroushani, B. K.; Saeidian, H.; Nourian, S.; Mirjafary, Z.;
Kiamehr, M. Pure Appl. Chem. 2011, 83, 709; (b) Moghaddam, F. M.; Saeidian,
H.; Mirjafary, Z.; Taheri, S.; Doulabi, M.; Kiamehr, M. Tetrahedron 2010, 50,
6723; (c) Moghaddam, F. M.; Saeidian, H.; Mirjafary, Z.; Taheri, S.; Kheirjou, S.
Synlett 2009, 1047.
1. (a) Baudelle, R.; Melnyk, P.; Deprez, B.; Tartar, A. Tetrahedron 1998, 54, 4125;
(b) Yamanaka, M.; Nishida, A.; Nakagana, M. Org. Lett. 2000, 2, 159; (c) Deligny,
M.; Carreaux, F.; Toupet, L.; Carboni, B. Adv. Synth. Catal. 2003, 345, 1215; (d)
Berkessel, A.; Erturk, E.; Laporte, C. Adv. Synth. Catal. 2006, 348, 223; (e) Yadav,
J. S.; Reddy, B. V. S.; Sadashiv, K.; Padmavani, B. Adv. Synth. Catal. 2004, 346, 607.
2. (a) Majumdar, K. C.; Taher, A.; Nandi, R. K. Tetrahedron 2012, 29, 5963; (b)
Majumder, S.; Bhuyan, P. Tetrahedron Lett. 2012, 53, 137; (c) Ghandi, M.;
Mohammadimehr, E.; Sadeghzadeh, M.; Bozcheloei, A. H. Tetrahedron 2011, 67,
8484; (d) Tietze, L. F.; Dietz, S.; Bohnke, N.; Dufert, M. A.; Objartel, I.; Stalke, D.
Eur. J. Org. Chem 2011, 6547.
19. General procedure for the synthesis of compounds 3a–l and 4a–l: a mixture of
2-formylphenyl (E)-2-phenylethenyl sulfonate 1 (0.5 mmol) and indoline-2-
thione derivative 2 (0.6 mmol) in H2O (6 ml) was stirred at reflux temperature.
The progress of the reaction was monitored by TLC using petroleum ether–
EtOAc (2:1) as the eluent. After completion of the reaction (4 h) the crude
residue was purified by column chromatography on silica gel (petroleum
ether–EtOAc, 3:1) to afford a mixture of inseparable isomers 3 and 4. 9-Methyl-
7-phenyl-6a,7,9,13c-tetrahydro[1,2]benzoxathiino[40,30:4,5]thiopyrano[2,3-
b]indole 6,6-dioxide (3a, 4a): yellow powder, mp: 214–216 °C, yield; 80% (67:33
3. (a) Tietze, L. F.; Ott, C.; Gerke, K.; Buback, M. Angew. Chem., Int. Ed. Engl. 1993,
32, 1485; (b) Tietze, L. F. Chem. Rev. 1996, 96, 115; (c) Tietze, L. F.; Rackelmann,
N. Pure Appl. Chem. 2004, 76, 1967; (d) Tietze, L. F.; Brasche, G.; Gericke, K.
Domino Reactions in Organic Synthesis; Wiley-VCH, 2006.
dr). IR (KBr): 3417, 2923, 2846, 1722, 1614, 1465, 1377, 1145, 1093, 743 cmꢀ1
.
1H NMR (500 MHz, CDCl3): d = 3.68 (3H, s, NMe), {for 4a, 3.74 (3H, s, NMe)},
4.57 (1H, dd, J = 4.5, 10.8 Hz, CHSO3), {for 4a, 4.19 (1H, dd, J = 10.6, 11.5 Hz,
CHSO3)}, 4.62 (1H, d, J = 10.7 Hz, SCHPh), {for 4a, 4.77 (1H, d, J = 10.6 Hz,
SCHPh)}, 5.50 (1H, d, J = 4.5 Hz, CH), {for 4a, 5.16 (1H, d, J = 11.5 Hz, CH)}, 7.10–
7.42 (13H, m, Ar–H), {for 4a 7.17–7.45 (13H, m, Ar–H)}. 13C NMR (125 MHz,
CDCl3): d = 27.6, 38.8, 45.5, 62.0, 107.6, 116.9, 118.6, 119.3, 121.0, 121.4, 121.5,
125.7, 126.9, 127.4, 127.7, 127.8, 128.2, 128.7, 129.0, 129.4, 130.5, 137.3. Anal.
Calcd for C24H19NO3S2: C, 66.49; H, 4.42; N, 3.23. Found: C, 66.75; H, 4.38; N,
3.10.
4. (a) Carle, J. S.; Christophersen, C. J. Org. Chem. 1980, 45, 1586; (b) Sakabe, N.;
Sendo, Y.; Iijima, I.; Ban, Y. Tetrahedron Lett. 1969, 30, 2527; (c) Ohmoto, T.;
Koike, K. Chem. Pharm. Bull. 1984, 32, 170; (d) Shimizu, M.; Ishikawa, M.;
Komoda, Y.; Nkajima, T.; Yamaguchi, K.; Yoneda, N. Chem. Pharm. Bull. 1984, 32,
463; (e) Yamanaka, E.; One, M.; Kasamatsu, S.; Aimi, N.; Sakai, S. Chem. Pharm.
Bull. 1984, 32, 818; (f) Taniguchi, M.; Anjiki, T.; Nakagawa, M.; Hino, T. Chem.
Pharm. Bull. 1984, 32, 2544; (g) Hashimoto, Y.; Shudo, K.; Okamoto, T. Chem.
Pharm. Bull. 1984, 32, 4300; (h) Nakashima, Y.; Kawashima, Y.; Amanuma, F.;
Sota, K.; Tanaka, A.; Kameyama, T. Chem. Pharm. Bull. 1984, 32, 4271; (i) Kamijo,
S.; Yamamoto, Y. J. Org. Chem. 2003, 68, 4764.
20. Haffmann, R. W. Chem Rev. 1841, 1989, 89.
5. (a) Guillonneare, C.; Pierre, A.; Charton, Y.; Guilbaud, N.; Berthier, I. K.; Leonce,
S.; Michel, A.; Bisagni, I.; Atassi, G. J. Med. Chem. 1999, 42, 2191; (b) Haider, N.;
Sotero, E. Chem. Pharm. Bull. 2002, 50, 1479.